Cargando…

Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities

BACKGROUND: Injectable opioid agonist treatment (iOAT) is an effective option to support people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral OAT. However, iOAT has been criticised based on theoretical and practical grounds for its dosing policies: Current regu...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedmann, Zoe, Kinkel, Hans-Tilmann, Kühner, Claudia, Zsolnai, Andreas, Mick, Inge, Binder, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619267/
https://www.ncbi.nlm.nih.gov/pubmed/37915058
http://dx.doi.org/10.1186/s12954-023-00896-6